Replies to post #160560 on Vivos Inc (RDGL)

[nathanial]

After being here since 2018, 30-50 is not my target.

[SC8]

Neglecting that 4th meeting was/is back on this month. A complication came up requiring a meeting discussion. FDA doesn't waste time with unneeded meetings. Might be lucky and issue resolved a meeting, but the first three RDGL-FDA meetings resulted in suggestions for additional testing or expansion of testing.

[konshe]

For me, will not sell below $1.